Tiziana Life Sciences PLC - London-registered biotechnology company - Adds John Brancaccio to its board as a non-executive director. Brancaccio was formerly chief financial officer and chief operating officer of Eline Group, an entertainment and media company and until May 2017 was CFO of medical devices company Accelerated Technologies Inc.
Current stock price: 180.00 pence
Year-to-date change: up sharply from 41.00p
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.